SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-18-015428
Filing Date
2018-11-08
Accepted
2018-11-08 09:06:07
Documents
77
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 787669
2 ex31.htm EX-31 36495
3 ex32.htm EX-32 9636
  Complete submission text file 0001493152-18-015428.txt   5230580

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE btx-20180930.xml EX-101.INS 915813
5 XBRL SCHEMA FILE btx-20180930.xsd EX-101.SCH 68953
6 XBRL CALCULATION FILE btx-20180930_cal.xml EX-101.CAL 84972
7 XBRL DEFINITION FILE btx-20180930_def.xml EX-101.DEF 339678
8 XBRL LABEL FILE btx-20180930_lab.xml EX-101.LAB 419198
9 XBRL PRESENTATION FILE btx-20180930_pre.xml EX-101.PRE 374561
Mailing Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501
Business Address 1010 ATLANTIC AVENUE SUITE 102 ALAMEDA CA 94501 5105213390
BIOTIME INC (Filer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12830 | Film No.: 181168410
SIC: 2836 Biological Products, (No Diagnostic Substances)